136 related articles for article (PubMed ID: 38240314)
1. Neuroscience-Based Nomenclature (NbN): the Portuguese version of the new classification for psychopharmacological drugs.
Galduroz JCF; Zampronio AR; Vital MABF; Sallet PC; Zohar J; Andreatini R
Trends Psychiatry Psychother; 2024 Jan; ():. PubMed ID: 38240314
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy of substance use disorders in the neuroscience-based nomenclature (NbN).
Carton L; Nourredine M; Rolland B
Therapie; 2021; 76(2):127-136. PubMed ID: 33371988
[TBL] [Abstract][Full Text] [Related]
3. The Neuroscience-based Nomenclature Child & Adolescent (NbN C&A) for Psychotropic Medications: Innovation in Progress.
Cortese S; Singh MK; Novins DK
J Am Acad Child Adolesc Psychiatry; 2022 Nov; 61(11):1317-1318. PubMed ID: 35697264
[TBL] [Abstract][Full Text] [Related]
4. Herbal medicine for psychiatric disorders: Psychopharmacology and neuroscience-based nomenclature.
Tang SW; Tang WH; Leonard BE
World J Biol Psychiatry; 2019 Oct; 20(8):586-604. PubMed ID: 28649903
[No Abstract] [Full Text] [Related]
5. Neuroscience-based nomenclature as a teaching tool, introduction and pilot study.
Zemach S; Minkin Levy D; Zohar J
Int Clin Psychopharmacol; 2023 Sep; 38(5):329-335. PubMed ID: 37159166
[TBL] [Abstract][Full Text] [Related]
6. A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature.
Zohar J; Stahl S; Moller HJ; Blier P; Kupfer D; Yamawaki S; Uchida H; Spedding M; Goodwin GM; Nutt D
Eur Neuropsychopharmacol; 2015 Dec; 25(12):2318-25. PubMed ID: 26527055
[TBL] [Abstract][Full Text] [Related]
7. A new nomenclature for classifying psychotropic drugs.
Caraci F; Enna SJ; Zohar J; Racagni G; Zalsman G; van den Brink W; Kasper S; Koob GF; Pariante CM; Piazza PV; Yamada K; Spedding M; Drago F
Br J Clin Pharmacol; 2017 Aug; 83(8):1614-1616. PubMed ID: 28401576
[TBL] [Abstract][Full Text] [Related]
8. Neuroscience-Based Nomenclature for Psychotropic Medication.
Hutson E; Ellington E; Hardy L
J Psychosoc Nurs Ment Health Serv; 2023 Jul; 61(7):9-13. PubMed ID: 37389943
[TBL] [Abstract][Full Text] [Related]
9. Neuroscience-based Nomenclature (NbN) for Clinical Psychopharmacology and Neuroscience.
Uchida H; Yamawaki S; Bahk WM; Jon DI
Clin Psychopharmacol Neurosci; 2016 May; 14(2):115-6. PubMed ID: 27121422
[No Abstract] [Full Text] [Related]
10. Neuroscience-based Nomenclature (NbN) for Journal of Psychopharmacology.
Nutt DJ; Blier P
J Psychopharmacol; 2016 May; 30(5):413-5. PubMed ID: 27098017
[No Abstract] [Full Text] [Related]
11. [Newly developed nomenclature (Neuroscience-based Nomenclature)].
Uchida H; Yamawaki S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2016 Jun; 36(3):69-71. PubMed ID: 27506083
[TBL] [Abstract][Full Text] [Related]
12. Editorial: Neuroscience-based Nomenclature (NbN) replaces the current label of psychotropic medications in European Psychiatry.
Gorwood P; Frangou S; Heun R;
Eur Psychiatry; 2017 Feb; 40():123. PubMed ID: 28042981
[No Abstract] [Full Text] [Related]
13. Neuroscience-based Nomenclature (NbN): A call for action.
Zohar J; Kasper S
World J Biol Psychiatry; 2016 Aug; 17(5):318-20. PubMed ID: 27379490
[No Abstract] [Full Text] [Related]
14. Neuroscience-based Nomenclature: improving clinical and scientific terminology in research and clinical psychopharmacology.
Brühl AB; Sahakian BJ
Psychol Med; 2017 Jun; 47(8):1339-1341. PubMed ID: 28095940
[No Abstract] [Full Text] [Related]
15. Neuroscience-based nomenclature (NbN).
Worley L
Lancet Psychiatry; 2017 Apr; 4(4):272-273. PubMed ID: 28347426
[No Abstract] [Full Text] [Related]
16. A Neuroscience-Based Nomenclature (NbN) for Psychotropic Agents.
Frazer A; Blier P
Int J Neuropsychopharmacol; 2016 Aug; 19(8):. PubMed ID: 27488347
[No Abstract] [Full Text] [Related]
17. Gap between patients with schizophrenia and their psychiatrists on the needs to psychopharmacological treatment: A cross-sectional study.
Takahashi K; Yamazawa R; Suzuki T; Mimura M; Uchida H
Neuropsychopharmacol Rep; 2020 Sep; 40(3):232-238. PubMed ID: 32489004
[TBL] [Abstract][Full Text] [Related]
18. Progress on the Neuroscience-Based Nomenclature (NbN) for Psychotropic Medications.
Blier P; Oquendo MA; Kupfer DJ
Neuropsychopharmacology; 2017 Sep; 42(10):1927-1928. PubMed ID: 28181516
[No Abstract] [Full Text] [Related]
19. Prescribing stigma in mental disorders: A comparative study of Portuguese psychiatrists and general practitioners.
Almeida B; Samouco A; Grilo F; Pimenta S; Moreira AM
Int J Soc Psychiatry; 2022 Jun; 68(4):708-717. PubMed ID: 33730898
[TBL] [Abstract][Full Text] [Related]
20. A proposal for an updated neuropsychopharmacological nomenclature.
Zohar J; Nutt DJ; Kupfer DJ; Moller HJ; Yamawaki S; Spedding M; Stahl SM
Eur Neuropsychopharmacol; 2014 Jul; 24(7):1005-14. PubMed ID: 24630385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
